These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3707813)

  • 1. The interaction between i.v. theophylline and chronic oral dosing with slow release nifedipine in volunteers.
    Jackson SH; Shah K; Debbas NM; Johnston A; Peverel-Cooper CA; Turner P
    Br J Clin Pharmacol; 1986 Apr; 21(4):389-92. PubMed ID: 3707813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers.
    Debbas NM; Jackson SH; Shah K; Abrams SM; Johnston A; Turner P
    Br J Clin Pharmacol; 1986 Apr; 21(4):385-8. PubMed ID: 3707812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between chronic oral slow-release theophylline and single-dose intravenous erythromycin.
    Pasic J; Jackson SH; Johnston A; Peverel-Cooper CA; Turner P; Downey K; Chaput de Saintonge DM
    Xenobiotica; 1987 Apr; 17(4):493-7. PubMed ID: 3604256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interactions of theophylline and nifedipine].
    Luther R; Wichert H; Köhler E; Banditt P; Walther H
    Z Erkr Atmungsorgane; 1990; 174(2):97-103. PubMed ID: 2349818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of chronic dosing on theophylline clearance.
    Efthimiou H; Morgan DJ; Ioannides-Demos L; Raymond K; McLean AJ
    Br J Clin Pharmacol; 1984 May; 17(5):525-30. PubMed ID: 6733000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
    Valet SB; Schwartz RH; Brooks JG
    Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nifedipine and theophylline in asthma.
    Garty M; Cohen E; Mazar A; Ilfeld DN; Spitzer S; Rosenfeld JB
    Clin Pharmacol Ther; 1986 Aug; 40(2):195-8. PubMed ID: 3731682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic studies of nifedipine and digoxin co-administration.
    Koren G; Zylber-Katz E; Granit L; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):39-42. PubMed ID: 3957488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R; Billing B
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
    Uematsu T; Follath F; Vozeh S
    Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
    Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
    Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exercise and environmental heat on theophylline kinetics.
    Schlaeffer F; Engelberg I; Kaplanski J; Danon A
    Respiration; 1984; 45(4):438-42. PubMed ID: 6473926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
    Hendeles L; Iafrate RP; Weinberger M
    Clin Pharmacokinet; 1984; 9(2):95-135. PubMed ID: 6370542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.
    Schulz HU; Hartmann M; Steinijans VW; Huber R; Lührmann B; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S51-7. PubMed ID: 8793603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a sustained-release theophylline formulation.
    Trembath PW; Boobois SW
    Br J Clin Pharmacol; 1980 Apr; 9(4):365-9. PubMed ID: 7378252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of theophylline in patients following short-term intravenous infusion.
    Steinijans VW; Eicke R; Ahrens J
    Eur J Clin Pharmacol; 1982; 22(5):417-22. PubMed ID: 7117353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and clinical pharmacokinetics of theophylline after administration of a new sustained release tablet.
    Jonkman JH; Berg WC; de Vries K; de Zeeuw RA; Schoenmaker R; Grimberg N
    Eur J Clin Pharmacol; 1981; 21(1):39-44. PubMed ID: 7333345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
    Götz J; Sauter R; Steinijans VW; Jonkman JH
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.